David Breckenridge
Co-founder and Chief Scientific Officer · Setara Biosciences
Biotechnology · Series A
Latest raise
$90M
Date raised
October 30, 2026
Round
Series A
About David Breckenridge
a clinical-stage rare disease biotech formed by Actio Biosciences alums
- Who is David Breckenridge?
- David Breckenridge is listed as Co-founder and Chief Scientific Officer of Setara Biosciences, a biotechnology company.
- How much did Setara Biosciences raise?
- Setara Biosciences raised $90M in a Series A round on October 30, 2026 (3 days ago).
Get newly funded founders every week
A free weekly list of startups that just raised.